Format

Send to

Choose Destination
Ann Rheum Dis. 2014 Jun;73(6):951-3. doi: 10.1136/annrheumdis-2013-204934.

Is there a need for new agents with novel mechanisms of action in psoriatic arthritis?

Author information

1
Dublin Academic Medical Centre, Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital and The Conway Institute of Biomolecular and Biomedical Research, University College Dublin, , Dublin, Ireland.

KEYWORDS:

DMARDs (biologic); Psoriatic Arthritis; Treatment

PMID:
24790066
DOI:
10.1136/annrheumdis-2013-204934
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center